Evidence map›Paper›PMID 23165986›Full record

Trial reportFASEB journal : official publication of the Federation of American Societies for Experimental Biology2013

The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters.

Kjersti Aagaard, Joseph Petrosino, Wendy Keitel, Mark Watson, James Katancik, Nathalia Garcia, Shital Patel, Mary Cutting, Tessa Madden, Holli Hamilton and 5 more

3 registry-linked trialsOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 192 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 4 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02558179 unknown statusnot on this mapstarted 2015, after this paper: background citation

Prospective Multicenter Cross Sectional Study of the American International Biotechnology (AIBiotech) Gynecologene Test for the Evaluation of Bacterial Vaginosis/Vaginitis in Symptomatic Women

Typeobservational_patient_registrySponsorAmerican International BiotechnologyRan2015 to 2018Enrolled300ConditionsVaginosis, Bacterial
NCT03543644 nacompletednot on this mapstarted 2018, after this paper: background citation

A Randomized Controlled Trial of the Effect of Replacing Sugar-sweetened Beverages With Non-nutritive Sweetened Beverages or Water on Gut Microbiome and Metabolic Outcomes: STOP Sugars NOW Trial

TypeinterventionalSponsorUniversity of TorontoRan2018 to 2020Enrolled81ConditionsHealthy, Overweight and Obesity, Metabolic Syndrome, PreDiabetesArmsSugar-sweetened beverage (SSB), Non-nutritive sweetened beverages (NSB), Water
NCT06095076 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prospective Descriptive Study of the Cutaneous Microbiota of ICU Patients With Central Venous Catheter (ICMc)

TypeobservationalSponsorCentre Hospitalier de CayenneRan2023 to 2024Enrolled120ConditionsDysbiosis, Catheter-Related InfectionsArmsSkin swabbing, Data collection
3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 4 syntheses or guidelines pooled it, 389 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2017
    Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. L-Fucose-Dependent Biofilm Formation bybioRxiv : the preprint server for biology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Kjersti AagaardDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, USA. aagaardt@bcm.edu
Joseph Petrosino
Wendy Keitel
Mark Watson
James Katancik
Nathalia Garcia
Shital Patel
Mary Cutting
Tessa Madden
Holli Hamilton
Emily Harris
Dirk Gevers
Gina Simone
Pamela McInnes
James Versalovic
Baylor College of Medicine · USNational Institutes of Health · USWashington University in St. Louis · USEmmes (United States) · USMassachusetts Institute of Technology · USTexas Children's Hospital · USThe University of Texas Health Science Center at Houston · USUniversity of Missouri–St. Louis · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Sequencing the Human MicrobiomeU54HG004968 · NHGRI · WASHINGTON UNIVERSITY · PI WEINSTOCK, GEORGE M · 2009 to 2012
$16.7M
A Microbial Genome Reference Platform for MetagenomicsU54HG004973 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A, HIGHLANDER, SARAH KATHERINE · 2009 to 2010
$1.8M
EVALUATION AND TESTING OF A DECISION SUPPORT AID IN CONTRACEPTIVE DECISION MAKINGK23HD070979 · NICHD · WASHINGTON UNIVERSITY · PI MADDEN, TESSA · 2012 to 2014
$367k
NHGRI NIH HHS U54 HG004968NHGRI NIH HHS U54HG004968NHGRI NIH HHS U54 HG004973NHGRI NIH HHS U54HG004973NICHD NIH HHS K23 HD070979NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

The Human Microbiome Project used rigorous good clinical practice standards to complete comprehensive body site sampling in healthy 18- to 40-yr-old adults, creating an unparalleled reference set of microbiome specimens. To ensure that specimens represented minimally perturbed microbiomes, we first screened potential participants using exclusion criteria based on health history, including the presence of systemic diseases (e.g., hypertension, cancer, or immunodeficiency or autoimmune disorders), use of potential immunomodulators, and recent use of antibiotics or probiotics. Subsequent physical examinations excluded individuals based on body mass index (BMI), cutaneous lesions, and oral health. We screened 554 individuals to enroll 300 (149 men and 151 women, mean age 26 yr, mean BMI 24 kg/m, 20.0% racial minority, and 10.7% Hispanic). We obtained specimens from the oral cavity, nares, skin, gastrointestinal tract, and vagina (15 specimens from men and 18 from women). The study evaluated longitudinal changes in an individual's microbiome by sampling 279 participants twice (mean 212 d after the first sampling; range 30-359 d) and 100 individuals 3 times (mean 72 d after the second sampling; range 30-224 d). This sampling strategy yielded 11,174 primary specimens, from which 12,479 DNA samples were submitted to 4 centers for metagenomic sequencing. Our clinical design and well-defined reference cohort has laid a foundation for microbiome research.

Indexed as

MetagenomeAdolescentAdultBody Mass IndexFemaleGastrointestinal TractHumansMaleMouthSkinSpecimen HandlingVagina

Identifiers

PMID23165986
PMCPMC3574278
OpenAlexW2167415413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.